Welcome to the Rosen Law Firm Blog Class Action Lawsuit Alert: ESSA Pharma Inc. New York, Jan. 31, 2025 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, has announced that a shareholder has filed a class action lawsuit on behalf of purchasers and acquirers of securities of ESSA Pharma Inc. (NASDAQ:…
High-Yield Stocks: Navigating the Current Landscape Introduction High-yield stocks are facing some challenges in today’s market, but there are still opportunities to be found. In particular, there are two sectors within the high-yield space that are experiencing significant tailwinds. In this article, I will discuss some of my top picks in these sectors and why…
Euro Continues To Rise Against US Dollar Prospects of Ukraine Peace Deal and Tariff Delay Boost EUR Charmingly eccentric, full of personality, and designed for maximum reader engagement, the Euro (EUR) has continued to drift higher against the US Dollar (USD) on the back of positive news. The EUR was last seen at 1.0479, showcasing…
Understanding Your Options After Suffering a Loss on AstraZeneca PLC (AZN) Investment: A Detailed Analysis Investing in the stock market comes with inherent risks. Despite thorough research and careful consideration, sometimes investments don’t perform as expected. One such investment that has recently underperformed is AstraZeneca PLC (AZN). If you find yourself in this situation, it’s…
Class Action Lawsuit Filed Against Monolithic Power Systems: What Does This Mean for Investors and the World? On March 7, 2025, Levi & Korsinsky, LLP announced the filing of a class action securities lawsuit against Monolithic Power Systems Inc. (Monolithic or the Company) (NASDAQ: MPWR). The lawsuit alleges securities fraud against the Company and seeks…
Fineqia International Inc’s Game-Changing Partnership with ETPLink: A New Era for Exchange-Traded Notes In a recent press release, Fineqia International Inc (CSE: Fernq, OTC: FNQQF) made an exciting announcement that is set to revolutionize the exchange-traded notes (ETNs) industry. The Canadian finance company’s subsidiary, Fineqia AG, has partnered with ETPLink to integrate distributed ledger technology…
Adial Pharmaceuticals: Business Update and 2024 Financial Results Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company specializing in the development of therapies for addiction and related disorders, recently released its business update and financial results for the year ended December 31, 2024. The Company reported significant progress in its clinical programs and financial performance. Clinical Programs…
Breaking News: Enovis Set to Expand with Acquisition of Limacorporate S.p.A. Creating a high-growth, global reconstruction leader with ~$1 billion in annual revenue Attractive margin profile and meaningful synergies expected to increase profitability Wilmington, DE, Sept. 25, 2023 (GLOBE NEWSWIRE) — Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”), an innovation-driven, medical technology growth company,…
